Reports and Data estimates the global Endocrine Testing competitive landscape is highly fragmented with numerous players operating on a global and regional scale. The key companies in the market are engaged in mergers and acquisitions, joint ventures, collaborations, and product launches to gain a robust revenue growth over the forecast period. The report considers 2020-2021 as historic years, 2020 as the base year, and 2019-2027 as the forecast period. The report offers CAGR and market size for the global Endocrine Testing during the forecast period.

The report also offers key insights about the top companies operating in the market and their market share and global position along with product portfolio and advancements. The top companies in the market include AB Sciex, Abbott Laboratories, Beckman Coulter, bioMerieux SA, BioRad Laboratories, Biomedical Technologies, Agilent Technologies, Quest Diagnostics, Diasorin, Hoffmann- La Roche Ltd., Thermo Fisher Scientific, and Siemens Healthineers, among others.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2240

Endocrine Testing Overview :-

The endocrine testing market is projected to grow at a rate of 8.1% in terms of value, from USD 8.67 Billion in 2019 to reach USD 16.30 Billion by 2027. The endocrine test performs a diagnosis of the endocrine glands, consisting of Pituitary glands, thyroid glands, adrenal glands, and pancreas, secrete hormones in the blood, and aid in normal body functioning. The endocrine tests include measuring the concentration of such endocrinal hormones in urine or blood. The high level of such hormones marks the presence of endocrinal diseases such as infertility, diabetes, and Cushing syndrome, among others. According to the American Thyroid Association, more than 12% of the US population will develop a thyroid disorder during their lifetime, and according to the study published by the Indian Journal of Endocrinology and Metabolism (IJEM), India has an incidence of 11.0% of the thyroid. Thyroid dysfunction, i.e., hyperthyroidism and hypothyroidism, are the most prevalent endocrinal diseases in developing countries, which is expected to propel the market growth.

Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness obesity are some of the key factors projected to hype the demand for Endocrine testing, thereby propelling the market growth. The increasing government support is expected to surge the early diagnosis, thus contributing to the growth of the market. Furthermore, the aging demographics is one of the key contributors to market growth, given the increased susceptibility to chronic endocrinal diseases and the risk of developing medical complications at an old age, which makes continuous medical tests and monitoring essential.

Inquiry more about to report @ https://www.reportsanddata.com/inquiry-before-buying/2240

For the purpose of this report Reports and Data has segmented global Endocrine Testing market on the basis of type, application, and region:

Test Type Outlook (Revenue, USD Million; 2017-2027)

• Estradiol
• TSH
• Insulin
• Cortisol
• FSH
• hCG
• LH
• DHEAS
• Progesterone
• Testosterone
• Prolactin
• Others

Technology Type Outlook (Revenue, USD Million; 2017-2027)

• Tandem Mass Spectrometry Immunoassay
• Monoclonal Polyclonal antibody technologies
• Sensor technology
• Clinical chemistry
• Others

End-Use Industry Outlook (Revenue, USD Million; 2017-2027)

• Hospital
• Commercial Laboratory
• Ambulatory Care Centers
• Others

Key Regional Markets Covered in the Report:

• North America (U.S.A., Canada, Mexico)
• Europe (Italy, U.K., Germany, France, Rest of Europe)
• Asia Pacific (India, China, Japan, South Korea, Australia, Rest of Asia Pacific)
• Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)

Request a customization on the report  https://www.reportsanddata.com/request-customization-form/2240

 Key Questions answered by the Report:

• What is the expected year-on-year growth of the Endocrine Testing during the forecast period?
• What key trends are expected influence revenue growth of the market going ahead?
• Which region is expected to account for largest revenue share over the forecast period?
• Which key companies are profiled in the report?

Thanks for reading our report. For more details on customization, please connect with us to know more and our team will ensure the report is well suited to your needs.

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs